Back to Stakeholders
Categories
1 domain / 2 areas / 1 specialization
Jiangsu HengRui Medicine Co., Ltd.
Data updated
China
1 Trial
Jiangsu HengRui Medicine Co., Ltd. is one of China's largest publicly listed pharmaceutical companies, specializing in innovative drugs across oncology, anesthesia, and metabolic diseases. The company has developed HR071603, a proprietary ketamine nasal spray candidate, which entered Phase I clinical evaluation in healthy subjects.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Quick Facts
- Type
- Public Biotech
- HQ
- China
- Website
- Visit